Concentra Group Holdings Parent, Inc.

CON Healthcare Medical Care Facilities

Concentra Group Holdings Parent, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 13.9% from fiscal 2024.

Revenue
+8.61%
EPS
+36.8%
Free cash flow
−19.8%
Total debt
−5.65%

Quarter to September 2026, against a year earlier

42.16 1.40 −3.21%
Market cap
$5.4B
P/E
24.9×
Fwd P/E
25.2×
Dividend yield
0.59%
F-score
6/9
Altman Z
1.85
Beneish M
−2.49
Dividend safety
62/100

Concentra Group Holdings Parent, Inc. (CON) EBITDA

Alert me on EBITDA

Concentra Group Holdings Parent, Inc.'s EBITDA for fiscal 2025 was $413.8M, up 10.7% from $373.6M in fiscal 2024. Over the twelve months to 30 September 2026 it was $479.6M. Over the past ten years it has ranged from $332.2M (fiscal 2022) to $413.8M (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 3 consecutive fiscal years. Concentra Group Holdings Parent, Inc. ranks 13th of 48 Medical Care Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $413.8M 10.74%
FY2024 $373.6M 3.59%
FY2023 $360.7M 8.58%
FY2022 $332.2M (14.29%)
FY2021 $387.6M —

Quarterly newest first

Period EBITDA Change
Sep 2026 $136.4M 0.28%
Jun 2026 $136.0M 16.96%
Mar 2026 $116.3M 27.87%
Dec 2025 $90.9M (21.18%)
9 more quarters

Against its own ten years

Low $332.2M High $413.8M
Ten-year median $373.6M
Current reading's percentile 100

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on CON